FDA Approves Marketing of First Device to Treat ADHD
MONDAY, April 22, 2019 -- Marketing has been approved for the first medical device to treat attention-deficit/hyperactivity disorder (ADHD), the U.S. Food and Drug Administration announced Friday.
The Monarch external Trigeminal Nerve Stimulation...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: ADHD | Food and Drug Administration (FDA) | Hyperactivity | Marketing | Medical Devices | Pharmaceuticals